CARDIAC INVOLVEMENT IN PEDIATRIC SEPSIS
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Sepsis-induced myocardial dysfunction (SIMD) occurs in 18-50% of pediatric patients with septic shock and significantly increases mortality. This condition represents one of the most serious complications encountered in pediatric intensive care units, and early diagnosis with appropriate management strategies is critical for reducing in-hospital mortality.The pathophysiology involves mitochondrial dysfunction, inflammatory cytokines (especially interleukin-8), nitric oxide, and calcium homeostasis disruption. Impaired mitochondrial energy production, decreased activity in electron transport chain complexes, and increased reactive oxygen species result in cellular energy failure. High interleukin-8 (IL-8) levels are strongly associated with SIMD risk. Recent studies suggest that myocardial dysfunction may be partially adaptive (“metabolic hibernation”) rather than purely pathological. According to this hypothesis, the myocardium protects itself by reducing energy consumption and prevents adenosine triphosphate (ATP) depletion in the presence of mitochondrial damage.In echocardiographic evaluation, diastolic function parameters (E/e’ ratio, e’ wave) and right ventricular function (tricuspid annular plane systolic excursion [TAPSE]) are stronger predictors of mortality than systolic parameters. An elevated E/e’ ratio indicates increased left ventricular filling pressures and is strongly associated with mortality. TAPSE value was found to be the strongest predictor of mortality. Ejection fraction is a less reliable parameter due to its load-dependency and potential to miss subendocardial dysfunction.Biomarker-based risk assessment models, particularly the PEdiatRic SEpsis biomarkEr Risk modEl-II (PERSEVERE-II), can predict SIMD risk with high accuracy through inflammatory markers. PERSEVERE-II predicts mortality risk using five biomarkers (IL-8, chemokine ligand 3 [CCL3], matrix metalloproteinase-8 [MMP8], heat shock protein family A member 1B [HSPA1B], Granzyme B), platelet count, and age. Interleukin-8-based models can predict SIMD development with high accuracy, and elevated lactate levels also serve as an important risk indicator.Echocardiography-guided individualized approach, early diagnosis, and appropriate inotrope selection are critical in management. Dobutamine or milrinone is recommended for patients with low ejection fraction, while norepinephrine is preferred in vasodilated shock. Levosimendan may be considered as an alternative option in cases resistant to conventional inotropes. Since SIMD is fully reversible within 7-10 days in the majority of survivors, aggressive supportive therapy is required during the acute phase. This reversible nature supports the hypothesis that SIMD may represent an adaptive response.Keywords: Pediatric sepsis; Myocardial dysfunction; Echocardiography; PERSEVERE; Biomarkers; TAPSE; Diastolic dysfunction
Fields of Study & Subjects
Sepsis Diagnosis and Treatment
Cardiovascular Function and Risk Factors
Takotsubo Cardiomyopathy and Associated Phenomena
Publication details
- Journal / source
- Turkiye Klinikleri eBooks
- Pages
- 317–326
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Book chapter